Liang Ma

机构：Hebei Medical University, Changzhi Medical College, Soochow University, The First People's Hospital of Changzhou, Fourth Hospital of Hebei Medical University, Qilu Hospital of Shandong University, Anhui University of Technology · ORCID：0000-0001-9131-4512

发表论文 73 篇 · 总被引 1290 次 · h-index 19

代表论文

• Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer (2021 · Cell Death and Disease · 被引 57)
• Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties (2022 · Bioorganic Chemistry · 被引 25)
• A novel 8-hydroxyquinoline derivative induces breast cancer cell death through paraptosis and apoptosis (2022 · APOPTOSIS · 被引 20)
• Fibroblasts facilitate lymphatic vessel formation in transplanted heart (2024 · Theranostics · 被引 16)
• Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells (2022 · Medical Oncology · 被引 12)
• Incidence and Influencing Factors of Chronic Postthoracotomy Pain in Lung Tumor Patients (2022 · Journal of Healthcare Engineering · 被引 8)